Citations (52)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (52)
Asmaa Elrakaybi, Dietrich A. Ruess, Michael Lübbert, Michael Quante & Heiko Becker. (2022) Epigenetics in Pancreatic Ductal Adenocarcinoma: Impact on Biology and Utilization in Diagnostics and Treatment. Cancers 14:23, pages 5926.
Crossref
Crossref
Zhi Hung Yap, Wei Yang Kong, Abdur Rahmaan Azeez, Chee-Mun Fang & Siew Ching Ngai. (2022) Anti-Cancer Effects of Epigenetics Drugs Scriptaid and Zebularine in Human Breast Adenocarcinoma Cells. Anti-Cancer Agents in Medicinal Chemistry 22:8, pages 1582-1591.
Crossref
Crossref
Xue-Song Xiang, Peng-Cheng Li, Wen-Quan Wang & Liang Liu. (2022) Histone deacetylases: A novel class of therapeutic targets for pancreatic cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1877:1, pages 188676.
Crossref
Crossref
Nianhong Chen, Qiaoqiao Zheng, Guoqing Wan, Feng Guo, Xiaobin Zeng & Ping Shi. (2021) Impact of posttranslational modifications in pancreatic carcinogenesis and treatments. Cancer and Metastasis Reviews 40:3, pages 739-759.
Crossref
Crossref
Manali Patki, Aishwarya Saraswat, Shraddha Bhutkar, Vikas Dukhande & Ketan Patel. (2021) In vitro assessment of a synergistic combination of gemcitabine and zebularine in pancreatic cancer cells. Experimental Cell Research 405:2, pages 112660.
Crossref
Crossref
Mingtan Tang, Lina Lozano Hernandez, Joy N. Reginald-Opara, Darren Svirskis, Euphemia Leung, Hongbo Wang & Zimei Wu. (2021) Zebularine suppressed gemcitabine-induced senescence and improved the cellular and plasma pharmacokinetics of gemcitabine, augmented by liposomal co-delivery. International Journal of Pharmaceutics 602, pages 120659.
Crossref
Crossref
Mariam Markouli, Dimitrios Strepkos, Efthimia K. Basdra, Athanasios G. Papavassiliou & Christina Piperi. (2021) Prominent Role of Histone Modifications in the Regulation of Tumor Metastasis. International Journal of Molecular Sciences 22:5, pages 2778.
Crossref
Crossref
K.S. Kavya Satheesh, Harsha Rani, Mohit Kumar Jolly & Vijayalakshmi Mahadevan. 2021. Epigenetics and Metabolomics. Epigenetics and Metabolomics
237
264
.
R¯uta Navakauskien˙e, Dalius Navakauskas, Veronika Borutinskait˙e & Dalius Matuzevi˘ciusRūta Navakauskienė, Dalius Navakauskas, Veronika Borutinskaitė & Dalius Matuzevičius. 2021. Epigenetics and Proteomics of Leukemia. Epigenetics and Proteomics of Leukemia
67
122
.
Roshmi R Sarma, Richard J Edwards, Ondi L Crino, Harrison J F Eyck, Paul D Waters, Michael R Crossland, Richard Shine & Lee A Rollins. (2020) Do Epigenetic Changes Drive Corticosterone Responses to Alarm Cues in Larvae of an Invasive Amphibian?. Integrative and Comparative Biology 60:6, pages 1481-1494.
Crossref
Crossref
Natalia Anahi Juiz, Juan Iovanna & Nelson Dusetti. (2019) Pancreatic Cancer Heterogeneity Can Be Explained Beyond the Genome. Frontiers in Oncology 9.
Crossref
Crossref
Huitong Ruan, Quanyin Hu, Di Wen, Qian Chen, Guojun Chen, Yifei Lu, Jinqiang Wang, Hao Cheng, Weiyue Lu & Zhen Gu. (2019) A Dual‐Bioresponsive Drug‐Delivery Depot for Combination of Epigenetic Modulation and Immune Checkpoint Blockade. Advanced Materials 31:17, pages 1806957.
Crossref
Crossref
Yong-Heng Luo, Juan Chen, En-Hua Xiao, Qiu-Yun Li & Yong-Mei Luo. (2018) Zebularine Promotes Hepatic Differentiation of Rabbit Bone Marrow Mesenchymal Stem Cells by Interfering with p38 MAPK Signaling. Stem Cells International 2018, pages 1-9.
Crossref
Crossref
Khushboo Agrawal, Viswanath Das, Pankhuri Vyas & Marián Hajdúch. (2018) Nucleosidic DNA demethylating epigenetic drugs – A comprehensive review from discovery to clinic. Pharmacology & Therapeutics 188, pages 45-79.
Crossref
Crossref
Tong Jin, Jianyu Hao & Daiming Fan. (2018) Nicotine induces aberrant hypermethylation of tumor suppressor genes in pancreatic epithelial ductal cells. Biochemical and Biophysical Research Communications 499:4, pages 934-940.
Crossref
Crossref
Henrieta Škovierov�, Ter�zia Okajčekov�, J�n Strn�del, Eva Vidomanov� & Erika Halašov�. (2017) Molecular regulation of epithelial-to-mesenchymal transition in tumorigenesis (Review). International Journal of Molecular Medicine.
Crossref
Crossref
Junzhong Lai, Hanze Wang, Qianping Luo, Shanlu Huang, Shujin Lin, Yansong Zheng & Qi Chen. (2017)
The relationship between DNA methylation and
Reprimo
gene expression in gastric cancer cells
. Oncotarget 8:65, pages 108610-108623.
Crossref
Crossref
Shijuan Du, Ge Xu, Wenqin Zou, Tingxiu Xiang & Ziguo Luo. (2017) Effect of dihydroartemisinin on UHRF1 gene expression in human prostate cancer PC-3 cells. Anti-Cancer Drugs 28:4, pages 384-391.
Crossref
Crossref
C. M. Fulkerson, D. Dhawan, D. R. Jones, V. E. Marquez, P. A. Jones, Z. Wang, Q. Wu, J. E. Klaunig, L. M. Fourez, P. L. Bonney & D. W. Knapp. (2017) Pharmacokinetics and toxicity of the novel oral demethylating agent zebularine in laboratory and tumor bearing dogs. Veterinary and Comparative Oncology 15:1, pages 226-236.
Crossref
Crossref
Dzjemma Sarkisjan, Renske D. M. Steenbergen, Jacqueline Cloos & Godefridus J. Peters. 2017. Chemotherapy for Leukemia. Chemotherapy for Leukemia
311
326
.
Sladjana Zagorac, Sonia Alcala, Gustavo Fernandez Bayon, Tony Bou Kheir, Matthieu Schoenhals, Anna González-Neira, Mario Fernandez Fraga, Alexandra Aicher, Christopher Heeschen & Bruno SainzJr.Jr.. (2016) DNMT1 Inhibition Reprograms Pancreatic Cancer Stem Cells via Upregulation of the miR-17-92 Cluster. Cancer Research 76:15, pages 4546-4558.
Crossref
Crossref
Simone Maschauer, Susanne Gahr, Muktheshwar Gandesiri, Philipp Tripal, Regine Schneider-Stock, Torsten Kuwert, Matthias Ocker & Olaf Prante. (2016) In vivo monitoring of the anti-angiogenic therapeutic effect of the pan-deacetylase inhibitor panobinostat by small animal PET in a mouse model of gastrointestinal cancers. Nuclear Medicine and Biology 43:1, pages 27-34.
Crossref
Crossref
Rajesh Singh, James W. LillardJr.Jr. & Shailesh Singh. 2016. Epigenetic Advancements in Cancer. Epigenetic Advancements in Cancer
27
63
.
Chen-Shuang Li, Haijun Tian, Min Zou, Ke-Wei Zhao, Yawei Li, Lifeng Lao, Elsa J. Brochmann, M. Eugenia L. Duarte, Michael D. Daubs, Yan-Heng Zhou, Samuel S. Murray & Jeffrey C. Wang. (2015) Secreted phosphoprotein 24 kD (Spp24) inhibits growth of human pancreatic cancer cells caused by BMP-2. Biochemical and Biophysical Research Communications 466:2, pages 167-172.
Crossref
Crossref
Kazuaki Nakamura, Kazuhiko Nakabayashi, Kyaw Htet Aung, Kazuko Aizawa, Naoko Hori, Junji Yamauchi, Kenichiro Hata & Akito Tanoue. (2015) DNA Methyltransferase Inhibitor Zebularine Induces Human Cholangiocarcinoma Cell Death through Alteration of DNA Methylation Status. PLOS ONE 10:3, pages e0120545.
Crossref
Crossref
Sibaji Sarkar, Garrick Horn, Kimberly Moulton, Anuja Oza, Shannon Byler, Shannon Kokolus & McKenna Longacre. (2013) Cancer Development, Progression, and Therapy: An Epigenetic Overview. International Journal of Molecular Sciences 14:10, pages 21087-21113.
Crossref
Crossref
Kazuaki Nakamura, Kazuko Aizawa, Kazuhiko Nakabayashi, Natsuko Kato, Junji Yamauchi, Kenichiro Hata & Akito Tanoue. (2013) DNA Methyltransferase Inhibitor Zebularine Inhibits Human Hepatic Carcinoma Cells Proliferation and Induces Apoptosis. PLoS ONE 8:1, pages e54036.
Crossref
Crossref
PIETRO DI FAZIO, ROBERTA MONTALBANO, KARL QUINT, BEATE ALINGER, RALF KEMMERLING, TOBIAS KIESSLICH, MATTHIAS OCKER & DANIEL NEUREITER. (2013) The pan-deacetylase inhibitor panobinostat modulates the expression of epithelial-mesenchymal transition markers in hepatocellular carcinoma models. Oncology Letters 5:1, pages 127-134.
Crossref
Crossref
TOBIAS KIESSLICH, MARTIN PICHLER & DANIEL NEUREITER. (2013) Epigenetic control of epithelial-mesenchymal-transition in human cancer. Molecular and Clinical Oncology 1:1, pages 3-11.
Crossref
Crossref
Ganji Purnachandra Nagaraju & Bassel F. EI-Rayes. (2013) SPARC and DNA methylation: Possible diagnostic and therapeutic implications in gastrointestinal cancers. Cancer Letters 328:1, pages 10-17.
Crossref
Crossref
Wei Tan, Wei Zhou, Hong-gang Yu, He-Sheng Luo & Lei Shen. (2013) The DNA methyltransferase inhibitor zebularine induces mitochondria-mediated apoptosis in gastric cancer cells in vitro and in vivo. Biochemical and Biophysical Research Communications 430:1, pages 250-255.
Crossref
Crossref
Nancy H. Nabilsi, Carolina E. Pardo, Maria Zajac-Kaye & Michael P. Kladde. 2013. Cell and Molecular Biology of Breast Cancer. Cell and Molecular Biology of Breast Cancer
211
259
.
Steffen Zopf, Matthias Ocker, Daniel Neureiter, Beate Alinger, Susanne Gahr, Markus F Neurath & Pietro Di Fazio. (2012) Inhibition of DNA methyltransferase activity and expression by treatment with the pan-deacetylase inhibitor panobinostat in hepatocellular carcinoma cell lines. BMC Cancer 12:1.
Crossref
Crossref
Min Chen, Daniel Shabashvili, Akbar Nawab, Sherry X. Yang, Lisa M. Dyer, Kevin D. Brown, Melinda Hollingshead, Kent W. Hunter, Frederic J. Kaye, Steven N. Hochwald, Victor E. Marquez, Patricia Steeg & Maria Zajac-Kaye. (2012) DNA Methyltransferase Inhibitor, Zebularine, Delays Tumor Growth and Induces Apoptosis in a Genetically Engineered Mouse Model of Breast Cancer. Molecular Cancer Therapeutics 11:2, pages 370-382.
Crossref
Crossref
Jurate Savickiene, Grazina Treigyte, Veronika-Viktorija Borutinskaite & Ruta Navakauskiene. (2012) Antileukemic activity of combined epigenetic agents, DNMT inhibitors zebularine and RG108 with HDAC inhibitors, against promyelocytic leukemia HL-60 cells. Cellular and Molecular Biology Letters 17:4.
Crossref
Crossref
Riccardo Turrini, Anna Merlo, Riccardo Dolcetti, Paola Zanovello & Antonio Rosato. (2011) Differential down-modulation of HLA class I and II molecule expression on human tumor cell lines upon in vivo transfer. Cancer Immunology, Immunotherapy 60:11, pages 1639-1645.
Crossref
Crossref
Sebastian Stintzing, Ralf Kemmerling, Tobias Kiesslich, Beate Alinger, Matthias Ocker & Daniel Neureiter. (2011) Myelodysplastic Syndrome and Histone Deacetylase Inhibitors: “To Be or Not to Be Acetylated”?. Journal of Biomedicine and Biotechnology 2011, pages 1-15.
Crossref
Crossref
Hidemi Rikiishi. (2010) Possible Role of Autophagy in the Treatment of Pancreatic Cancer with Histone Deacetylase Inhibitors. Cancers 2:4, pages 2026-2043.
Crossref
Crossref
Yi-kang Shi, Zhong-hua Li, Xi-qian Han, Ji-hu Yi, Zhen-hua Wang, Jing-li Hou, Cong-ran Feng, Qing-hong Fang, Hui-hui Wang, Peng-fei Zhang, Feng-shan Wang, Jie Shen & Peng Wang. (2010) The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces growth inhibition and enhances taxol-induced cell death in breast cancer. Cancer Chemotherapy and Pharmacology 66:6, pages 1131-1140.
Crossref
Crossref
Jesper B. AndersenValentina M. FactorJens U. MarquardtChiara RaggiYun-Han LeeDaekwan SeoElizabeth A. ConnerSnorri S. Thorgeirsson. (2010) An Integrated Genomic and Epigenomic Approach Predicts Therapeutic Response to Zebularine in Human Liver Cancer. Science Translational Medicine 2:54.
Crossref
Crossref
Madhavi Billam, Michele D. Sobolewski & Nancy E. Davidson. (2009) Effects of a novel DNA methyltransferase inhibitor zebularine on human breast cancer cells. Breast Cancer Research and Treatment 120:3, pages 581-592.
Crossref
Crossref
Taofeek K. Owonikoko, Suresh S. Ramalingam, Beatriz Kanterewicz, Trent E. Balius, Chandra P. Belani & Pamela A. Hershberger. (2009) Vorinostat increases carboplatin and paclitaxel activity in non‐small cell lung cancer cells. International Journal of Cancer 126:3, pages 743-755.
Crossref
Crossref
Kouko Tatsumi, Hiroaki Okuda, Manabu Makinodan, Takahira Yamauchi, Eri Makinodan, Hiroko Matsuyoshi, Takayuki Manabe & Akio Wanaka. (2010) Transient activation of Notch signaling in the injured adult brain. Journal of Chemical Neuroanatomy 39:1, pages 15-19.
Crossref
Crossref
Georg Feldmann & Anirban Maitra. 2010. Drug Discovery in Pancreatic Cancer. Drug Discovery in Pancreatic Cancer
181
204
.
Sebastian Stintzing, Matthias Ocker, Andrea Hartner, Kerstin Amann, Letterio Barbera & Daniel Neureiter. (2009) Differentiation patterning of vascular smooth muscle cells (VSMC) in atherosclerosis. Virchows Archiv 455:2, pages 171-185.
Crossref
Crossref
Yanfang Li, Wei Hu, De-Yu Shen, John J. Kavanagh & Siqing Fu. (2009) Azacitidine enhances sensitivity of platinum-resistant ovarian cancer cells to carboplatin through induction of apoptosis. American Journal of Obstetrics and Gynecology 200:2, pages 177.e1-177.e9.
Crossref
Crossref
Karl Quint, Sebastian Stintzing, Beate Alinger, Cornelia Hauser-Kronberger, Otto Dietze, Susanne Gahr, Eckhart G. Hahn, Matthias Ocker & Daniel Neureiter. (2009) The Expression Pattern of PDX-1, SHH, Patched and Gli-1 Is Associated with Pathological and Clinical Features in Human Pancreatic Cancer. Pancreatology 9:1-2, pages 116-126.
Crossref
Crossref
Aurelia Lahoz & Alan Hall. (2008) DLC1: a significant GAP in the cancer genome. Genes & Development 22:13, pages 1724-1730.
Crossref
Crossref
David Kuch, Lothar Schermelleh, Susanne Manetto, Heinrich Leonhardt & Thomas Carell. (2008) Synthesis of DNA Dumbbell Based Inhibitors for the Human DNA Methyltransferase Dnmt1. Angewandte Chemie International Edition 47:8, pages 1515-1518.
Crossref
Crossref
David Kuch, Lothar Schermelleh, Susanne Manetto, Heinrich Leonhardt & Thomas Carell. (2008) Synthese von hantelförmigen DNA‐Inibitoren für die humane DNA‐Methyltransferase Dnmt1. Angewandte Chemie 120:8, pages 1538-1541.
Crossref
Crossref
Martin Haefner, Thilo Bluethner, Manuel Niederhagen, Christian Moebius, Christian Wittekind, Joachim Mossner, Karel Caca & Marcus Wiedmann. (2008) Experimental treatment of pancreatic cancer with two novel histone deacetylase inhibitors. World Journal of Gastroenterology 14:23, pages 3681.
Crossref
Crossref
Hala Gali-Muhtasib, Matthias Ocker, Doerthe Kuester, Sabine Krueger, Zeina El-Hajj, Antje Diestel, Matthias Evert, Nahed El-Najjar, Brigitte Peters, Abdo Jurjus, Albert Roessner & Regine Schneider-Stock. (2007) Thymoquinone reduces mouse colon tumor cell invasion and inhibits tumor growth in murine colon cancer models. Journal of Cellular and Molecular Medicine 12:1, pages 330-342.
Crossref
Crossref